Naltrexon Accord (Naltrexone Hydrochloride)

Naltrexone Hydrochloride, the active ingredient in Naltrexon Accord, is an opioid antagonist presented as an oral tablet for oral use. It treats alcohol dependence and opioid dependence in adult patients.

GNH USA supplies Naltrexon Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, with a focus on regulatory compliance to ensure product integrity throughout the supply chain, supporting healthcare providers in delivering evidence‑based treatment.

Naltrexone is used in the management of substance dependence disorders, primarily affecting the central opioid pathways involved in alcohol and opioid addiction. - Alcohol dependence: reduces cravings and supports sustained abstinence in adults. - Opioid dependence: blocks opioid receptors to prevent relapse after detoxification. - Alcohol use disorder: assists in decreasing heavy drinking episodes during treatment. - Opioid use disorder maintenance: used as part of a comprehensive program to reduce opioid‑seeking behavior.

Naltrexone may be associated with a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Fatigue: feeling of reduced energy. - Insomnia: difficulty falling or staying asleep. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Depression or suicidal thoughts: worsening mood or emergence of suicidal ideation.

When prescribing Naltrexon Accord, clinicians should consider several precautionary measures to ensure safe use. - Liver function monitoring: assess baseline and periodic liver enzymes due to potential hepatotoxicity. - Concomitant opioid use: avoid because it can precipitate withdrawal symptoms. - Pregnancy and lactation: use only if potential benefit justifies risk, as safety data are limited. - Renal impairment: adjust use cautiously in patients with severe kidney dysfunction. - Psychiatric history: monitor for worsening depression or suicidal thoughts. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Naltrexone can interact with other medicines, altering efficacy or increasing adverse effects.

Major Interactions (Avoid): - Opioid analgesics: concurrent use may cause acute opioid withdrawal. - Disulfiram: combined use can intensify hepatotoxic risk. - Certain hepatotoxic drugs (e.g., isoniazid): may increase liver injury.

Moderate Interactions (Monitor Closely): - Benzodiazepines: may enhance central nervous system depression if withdrawal occurs. - Antidepressants (SSRIs): monitor mood changes as naltrexone can affect serotonin pathways. - Immunosuppressants: observe for altered drug levels when used together.